Skip to main content
Clinical Trials/NCT05527054
NCT05527054
Active, not recruiting
Not Applicable

Analysis of Risk Factors of Diuretics Related Acute Kidney Injury in Hospitalized Patients and Development of Machine Learning Model

Qianfoshan Hospital1 site in 1 country18,000 target enrollmentJuly 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diuretic Toxicity
Sponsor
Qianfoshan Hospital
Enrollment
18000
Locations
1
Primary Endpoint
Acute kidney injury
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

Acute kidney injury (AKI) is a series of clinical syndromes in which serum creatinine (Scr) concentrations increase over a short period of time, or urine output decreases. It has become an increasing global concern.Drug-induced acute kidney injury (D-AKI) refers to kidney injury caused by drugs or their metabolites within 7 days after the use of one or more drugs. The kidneys are rich in blood flow and have the function of acidifying the urine, making them an easy target for drug toxicity. Besides, there are enzymes in the kidney that metabolize some drugs, and if these drugs are metabolized abnormally in the kidney, substances toxic to the kidney may be produced.It was found that about 20% of AKI in hospitalized patients was caused by medications.Diuretics are one of the well-known nephrotoxic drugs, since they can directly or indirectly cause a significant decrease in renal blood perfusion and glomerular filtration rate through the mechanism of affecting tubulobulb feedback, which leads to kidney ischemia and hypoxia.However, there are few real-world studies on the incidence of AKI in hospitalized patients received diuretics. In this study, we aimed to explore the incidence and risk factors analysis of AKI in hospitalized patients received diuretics and develop the machine learning model for diuretics related AKI based on electronic medical record data. With the individual characteristics of patients, the risk of AKI can be evaluated before receiving diuretics, which may provide useful information for clinical decision making to better prevent D-AKI.

Registry
clinicaltrials.gov
Start Date
July 1, 2022
End Date
June 30, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Qianfoshan Hospital
Responsible Party
Principal Investigator
Principal Investigator

Xiao Li,MD

MD

Qianfoshan Hospital

Eligibility Criteria

Inclusion Criteria

  • All inpatients who used diuretics during hospitalization Hospital stay ≥ 48h Age ≥ 18 years There were two or more blood creatinine tests during hospitalization

Exclusion Criteria

  • Hospital stay \< 48h Age \< 18 years GFR \< 30ml/min/1.73m2 within 48 hours after admission AKI was diagnosed on admission Less than two Scr test results during hospitalization The Scr values were always lower than 40 μmol/L during hospitalization Cases with incomplete medical history information

Outcomes

Primary Outcomes

Acute kidney injury

Time Frame: Through study completion,up to half a year.

During the patient's hospitalization, acute kidney injury occurred after diuretic use.

Study Sites (1)

Loading locations...

Similar Trials